The Hypoxia Mimetic Protocatechuic Acid Ethyl Ester Inhibits Synaptic Signaling and Plasticity in the Rat Hippocampus

Neuroscience. 2018 Jan 15:369:168-182. doi: 10.1016/j.neuroscience.2017.11.011. Epub 2017 Nov 10.

Abstract

During hypoxia a number of physiological changes occur within neurons including the stabilization of hypoxia-inducible factors (HIFs). The activity of these proteins is regulated by O2, Fe2+, 2-OG and ascorbate-dependant hydroxylases which contain prolyl-4-hydroxylase domains (PHDs). PHD inhibitors have been widely used and have been shown to have a preconditioning and protective effect against a later and more severe hypoxic insult. In this study we have investigated the neuroprotective effects of the PHD inhibitor, protocatechuic acid ethyl ester (ethyl 3,4, dihydroxybenzoate: EDHB), as well as its effects on synaptic transmission and plasticity in the rat hippocampus using electrophysiological techniques. We report for the first time, an acute concentration-dependent and reversible inhibitory effect of EDHB (10-100 μM) on synaptic transmission in the dentate gyrus but not Cornu Ammonis 1 (CA1) region which does not affect cell viability. This effect was attenuated through the application of the NMDA or GABAA receptor antagonists, AP-5 and picrotoxin in the dentate gyrus. There were no changes in the ratio of paired responses after EDHB application suggesting a post-synaptic mechanism of action. EDHB (100 μM), was found to inhibit synaptic plasticity in both the dentate gyrus and CA1 regions. Application of exogenous Fe2+ (100 μM) or digoxin (100 nM) did not reverse EDHB's inhibitory effect on synaptic transmission or plasticity in both regions, suggesting that its effects may be HIF-independent. These results highlight a novel modulatory role for the PHD inhibitor EDHB in hippocampal synaptic transmission and plasticity. A novel post-synaptic mechanism of action may be involved, possibly involving NMDA and GABAA receptor activation.

Keywords: EPSP; LTP; hippocampus; hypoxia; prolyl hydroxylase; protocatechuic acid ethyl ester/ethyl 3,4, dihydroxybenzoate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • GABA-A Receptor Antagonists / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / physiology
  • Hydroxybenzoates / pharmacology*
  • Neuronal Plasticity / drug effects*
  • Neuronal Plasticity / physiology
  • Neuroprotective Agents / pharmacology*
  • Picrotoxin / pharmacology
  • Prolyl Hydroxylases / metabolism
  • Prolyl-Hydroxylase Inhibitors / pharmacology
  • Rats, Wistar
  • Receptors, GABA-A / metabolism
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Synapses / drug effects
  • Synapses / physiology
  • Synaptic Transmission / drug effects*
  • Synaptic Transmission / physiology
  • Tissue Culture Techniques

Substances

  • GABA-A Receptor Antagonists
  • Hydroxybenzoates
  • Neuroprotective Agents
  • Prolyl-Hydroxylase Inhibitors
  • Receptors, GABA-A
  • Receptors, N-Methyl-D-Aspartate
  • Picrotoxin
  • ethyl protocatechuate
  • Prolyl Hydroxylases